Observations on the microenvironmental nature of cartilage degradation in rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 56, Issue 3, 1997, Pages 151-161

  Woolley, David E ^a   Tetlow, Lynne C ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BONE REMODELING; CARTILAGE DEGENERATION; ENZYME ACTIVITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SHORT SURVEY;

EID: 0030989778     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.56.3.151     Document Type: Short Survey

References (57)

1. Woolley DE, Crossley MJ, Evanson JM. Collagenase at sites of cartilage erosion in the rheumatoid joint. Arthritis Rheum 1977;20:1231-9.
2. Woolley DE, Tetlow LC, Evanson JM. Collagenase immunolocalisation studies of rheumatoid and malignant tissues. In: Woolley DE, Evanson JM, eds. Collagenase in normal and pathological connective tissues. Chichester: John Wiley, 1980:105-25.
3. Woolley DE. Cellular mechanisms of cartilage destruction. In: Henderson B, Edwards J, Pettifer R, eds. Mechanisms and models in rheumatoid arthritis. London: Academic Press, 1995:115-32.
4. Tetlow LC, Woolley DE. Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies. Ann Rheum Dis 1995;54:896-903.
5. Bromley M, Woolley DE. Chondroclasts and osteoclasts at subchondral sites in the rheumatoid joint. Arthritis Rheum 1984;27:968-75.
6. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857-63.
7. Mohr W. Pathobiochemistry of cartilage destruction. J Clin Chem Clin Biochem 1986;24:949-51.
8. Bromley M, Fisher WD, Woolley DE. Mast cells at sites of cartilage erosion in the rheumatoid joint. Ann Rheum Dis 1984;43:76-9.
9. Mohr W, Menninger H. Polymorphonuclear granulocytes at the pannus-cartilage joint in rheumatoid arthritis (letter). Arthritis Rheum 1980;23:1413-4.
10. Allard SA, Muirden KD, Camplejohn KL, Maini RN. Chondrocyte-derived cells and matrix at the rheumatoid cartilage-pannus junction identified with monclonal antibodies. Rheumatol Int 1987;7:153-9.
11. Tetlow LC, Woolley DE. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann Rheum Dis 1995;54:549-55.
12. Mohr W, Wessinghage D. The relationship between polymorphonuclear granulocytes and cartilage destruction in rheumatoid arthritis. Z Rheumatol 1978;37:81-6.
13. Fassbender HG. Pathology of rheumatic diseases. Heidelberg: Springer-Verlag, 1975:75-137.
14. Harris ED. Pathogenesis of rheumatoid arthritis. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of rheumatology. Philadelphia: WB Saunders, 1989: 896-927.
15. Cush JJ, Lipsky PE. Cellular basis for rheumatoid inflammation. Clin Orthop Rel Res 1991;265:9-22.
16. Krane SM. Mechanisms of tissue destruction in rheumatoid arthritis. In:McCarry D J, Koopman WJ, eds. Arthritis and allied conditions. A textbook of rheumatology. Vol 1. Philadelphia: Lea & Febiger, 1993: 763-80.
17. Firestein GS, Zvaifler NJ. How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 1990; 33:768-73.
18. Bromley M, Bertfield H, Evanson JM, Woolley DE. Bidirectional erosion of cartilage in the rheumatoid knee joint. Ann Rheum Dis 1985;44:676-81.
19. Bogoch E, Gschwend N, Bogoch B, Rahn B, Perren S. Juxtaarticular bone in experimental arthritis. J Orthop Res 1988;6:648-56.
20. Uhlinger E. Bone changes in rheumatoid arthritis and their pathogenesis. In: Muller W, Harwerth HG, Fehr K, eds. Rheumatoid arthritis: pathogenicm mechanisms and consequences in therapeutics. London: Academic Press, 1971: 25-36.
21. Schenk RK, Spiro D, Wiener J. Cartilage resorption in the tibial epiphyseal plate of growing rats. J Cell Biol 1967;34:275-91.
22. Poole AR. Cartilage in health and disease. In:McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions. A textbook of rheumatology. Vol 1. Philadelphia: Lea & Febiger, 1993: 279-334.
23. Wyllie JC. Histopathology of the subchondral bone lesion in rheumatoid arthritis. J Rheumatol 1983;10:26-8.
24. Fassbender HG, Seibel M, Herbert T. Pathways of destruction in metacarpal and metatarsal joints of patients with rheumatoid arthritis. Scand J Rheumatol 1992;21:10-6.
25. Cooke TDV, Suni M, Maeda M. Deleterious interactions of immune complexes in cartilage of experimental immune arthritis: the erosion of pannus-free hyaline cartilage. Clin Orthop 1995;183:235-45.
26. Mitrovic D. The mechanism of cartilage destruction in rheumatoid arthritis (letter). Arthritis Rheum 1985; 28:1192-3.
27. Takasugi S, Inoue H. Pannus tissue at the cartilage-synovium junction in rheumatoid arthritis. Acta Med Okayama 1988;42:83-95.
28. Mohr W. Gelenkkrankheiten. Diagnostik und Pathogenese makroskopischer Strukturveranderungen. Stuttgart: Georg Thieme Verlag, 1984.
29. Woolley DE, Bromley M, Evanson JM. Reply to Dr Cooke (letter) Arthritis Rheum 1985;28:1197-8.
30. Arend WP, Dayer J-M. Inhibition of the production and effects of interleukin-1 and tumor necrosis factor a in rheumatoid arthritis. Arthritis Rheum 1995;38:151-60.
31. Taylor DJ, Yoffe JR, Brown DM, Woolley DE. Histamine stimulates prostaglandin E production by rheumatoid synovial cells and human articular chondrocytes in culture. Arthritis Rheum 1986;29:160-5.
32. 2 receptors on human articular chondrocytes. Ann Rheum Dis 1987;47:431-5.
33. Wilkinson LS, Pitsillides AA, Edwards JCW. Giant cells in arthritic synovium. Ann Rheum Dis 1993;52:182-4.
34. Woolley DE. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders? Ann Rheum Dis 1995:54:533-8.
35. Mican JM, Metcalfe DD. Arthritis and mast cell activation. J Allergy Clin Immunol 1990;86:677-83.
36. Gruber BL, Kaplan AP. Mast cells and rheumatic diseases. In: McCarty DJ, Koopman WJ, eds. Arthritis and allied conditions. A textbook of rheumatology 12th ed.Philadelphia: Lea and Febiger, 1993: 417-29.
37. Gadher SJ, Woolley DE. Comparative studies of adherent rheumatoid synovial cells in primary culture: characterisation of the dendritic (stellate) cell. Rheumatol Int 1987;23:13-22.
38. Brennan FM, Maini RN, Feldmann M. TNFα - a pivotal role in rheumatoid arthritis? Br J Rheumatol 1992; 31:293-8.
39. Chu CQ, Field M, Feldmann M, Main RN. Localisation of tumour necrosis factor α in synovial tissue and at the cartilage-pannus junction in patients with rheumatoid arthritis. Arthritis Rheum 1991;34:1125-32.
40. Chu CQ, Field M, Allard S, Abney E, Feldmann M, Maini RN. Detection of cytokines at the cartilage/pannus junction in patients with rheumatoid arthritis: implications for the role of cytokines in cartilage destruction and repair. Br J Rheumatol 1992;32:653-61.
41. Gordon JR, Galli SJ. Mast cells as a source of both preformed and immunologically inducible TNF-α/ cachetin. Nature 1990;346:274-6.
42. Birkedal-Hansen H, Moore WGI, Bodden MK, et al. Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993;4:197-250.
43. Nagase H, Woessner JF. Role of endogenous proteinases in the degradation of cartilage matrix. In: Woessner JF, Howell DS, eds. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker, 1993:159-85.
44. Cronstein BN, Weissman G. Neutrophil structure and functions. In: McCarty DJ, Koopman WJ. eds. Arthritis and allied conditions. A textbook of rheumatology. Vol 1.Philadelphia: Lea & Febiger, 1993:389-408.
45. Martel-Pelletier J, Pelletier J-P. Wanted - the collagenase responsible for the destruction of the collagen network in human cartilage! Br J Rheumatol 1996;35:818-20.
46. Mitchell PG, Magna HA, Reeves LM, et al. Cloning, expression and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97:761-8.
47. Cole AA, Kuettner KE. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop Scand 1995;66:98-102.
48. Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not synoviocytes: A role in osteoarthritis. J Clin Invest 1996:97:2011-9.
49. Morgan K. What do anti-collagen antibodies mean? Ann Rheum Dis 1990;49:62-5.
50. Morgan K, Buckee C, Collins I, Ayad S, Clague RB, Holt PJL. Antibodies to type II and XI collagens: evidence for the formation of antigen specific as well as cross reacting antibodies in patients with rheumatoid arthritis. Ann Rheum Dis 1988;47:1008-13.
51. Terato K, Shimozuru Y, Katayama K, et al. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum 1990;33:1493-500.
52. Cooper AL, Snowden N, Woolley DE. IgE antibodies specific for cartilage collagens type II, IX and XI in rheumatic diseases. Scand J Rheumatol 1993;22:207-14.
53. Poole AR. Immunology of cartilage. In: Moskowitz RW, Howell DS, et al, eds. Osteoarthritis, diagnosis and management. 2nd ed. Philadelphia, WB Saunders, 1991:155-89.
54. Kuettner KE, Pauli BU, Soble L. Morphological studies on the resistance of cartilage to invasion by osteosarcoma cells in vitro and in vivo. Cancer Res 1978;38:277-87.
55. Jasin HE, Taurog JD. Mechanisms of disruption of the articular cartilage surface in inflammation. J Clin Invest 1991;87:1531-6.
56. Campion GV. The prospect for cytokine based therapeutic strategies in rheumatoid arthritis. Ann Rheum Dis 1994;53:485-7.
57. Panayi GS. Therapy for rheumatoid arthritis. In:Henderson B, Edwards JCW, Pettipher ER, eds. Mechanisms and models in rheumatoid arthritis. San Diego: Academic Press, 1995:67-79.